Clinical Trial Update: Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.

View source ↗

Summary

A clinical trial sponsored by Istituto Oncologico Veneto IRCCS is evaluating financial toxicity using the PROFFIT questionnaire in patients undergoing minimally…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Kidney Cancer
• Prostate Cancer

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Prostate Cancer, Bladder Cancer | Status: RECRUITING